|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM238863506 |
003 |
DE-627 |
005 |
20231224114715.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2014 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1080/08997659.2013.860059
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0796.xml
|
035 |
|
|
|a (DE-627)NLM238863506
|
035 |
|
|
|a (NLM)24895858
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Hu, Kun
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Relationship between permeability glycoprotein (P-gp) gene expression and enrofloxacin metabolism in Nile Tilapia
|
264 |
|
1 |
|c 2014
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 04.09.2014
|
500 |
|
|
|a Date Revised 30.09.2020
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a The aim of this study was to analyze the influence of permeability glycoprotein (P-gp) gene expression on enrofloxacin (ENR) metabolism in aquatic animals. Nile Tilapia Oreochomis niloticus were fed different doses of ENR ranging from 0 to 80 mg/kg. The P-gp gene expression levels were determined by quantitative real-time PCR (qRT-PCR) at indicated time points after drug administration. Drug metabolism was determined by HPLC. The P-gp gene expression in liver and kidney was greatly enhanced 30 min after ENR administration at 40 mg/kg, peaked 3 h after drug administration, and then gradually decreased. Thirty minutes after a single oral administration of ENR (0, 20, 40, or 80 mg/kg), the P-gp gene expression increased in a dose-dependent manner. The P-gp gene expression levels in the kidney were significantly higher than those in the liver. Additionally, the metabolic rate of ENR in kidney was more rapid than that in liver. Furthermore, a close correlation was found between P-gp gene expression and ENR concentrations. These results suggest that P-gp may be involved in the ENR metabolism process in Nile Tilapia, providing a novel model for the potential utility of gene expression and drug metabolism studies in aquatic animals
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a ATP Binding Cassette Transporter, Subfamily B, Member 1
|2 NLM
|
650 |
|
7 |
|a Anti-Bacterial Agents
|2 NLM
|
650 |
|
7 |
|a Fluoroquinolones
|2 NLM
|
650 |
|
7 |
|a Enrofloxacin
|2 NLM
|
650 |
|
7 |
|a 3DX3XEK1BN
|2 NLM
|
700 |
1 |
|
|a Cheng, Gang
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhang, Haixin
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Huicong
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ruan, Jiming
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chen, Li
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Fang, Wenhong
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Yang, Xianle
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Journal of aquatic animal health
|d 1998
|g 26(2014), 2 vom: 28. Juni, Seite 59-65
|w (DE-627)NLM098202006
|x 1548-8667
|7 nnns
|
773 |
1 |
8 |
|g volume:26
|g year:2014
|g number:2
|g day:28
|g month:06
|g pages:59-65
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1080/08997659.2013.860059
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 26
|j 2014
|e 2
|b 28
|c 06
|h 59-65
|